lilly tirzepatide vial markets single-dose Zepbound vials at a major price cut The Weight Loss Drug That

Separate cards exist for Mounjaro (diabetes) and Zepbound (weight loss), each offering up to $563 in copay reduction per fill with a 13-fill annual limit

Clinical trials show that this careful titration approach helps your body adapt while reducing the risk of gastrointestinal side effects

Ultimately, available evidence suggests that the long-term safety profile of GLP-1 receptor agonists remains favorable for most patients who tolerate therapy during the early stages of treatment

Excess weight puts individuals at higher risk for chronic diseases like type 2 diabetes, heart disease, and certain cancers

Most plumping serums lean on hyaluronic acid or glycerin to pull in water and create a temporary filling effect